Bei der Diagnosestellung oder Überprüfung eines schon länger bestehenden Diabetes fällt es nicht immer leicht, Patienten z. B. eindeutig als Typ-1- oder Typ-2-Diabetiker einzuordnen. Denn manche haben einen „Doppeldiabetes“. Das hat auch therapeutische Konsequenzen.
Literatur
Hawa MI & Action LADA 7 Consortium. Adult-Onset Autoimmune Diabetes in Europe is Prevalent with a broad Clinical Phenotype. Diabetes Care 2013; 36:908–913
Turner R et al. Prospective Diabetes Study Group, UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes, Lancet 1997; 350:1288–1293
Tuomi T et al. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 2014; 383:1084–94
Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol 2014; 71:697–704
Krause S et al. GAD Autoantibody Affinity in Adult Patients with latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial. Diabetes Care 2014; 37:1675–1680
Williams A et al. Detection of Antibodies directed to the N-Terminal Region of GAD is dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes. Diabetes 2015; 65:3239–3246
Zhao Y, Yang L, Xiang Y, Liu L, Huang G, Long Z, Li X, Leslie RD, Wang X, Zhou Z. Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study. J Clin Endocrinol Metab 2014; 99:E876–80
Johansen OE, Boehm B, Grill V, Torjesen PA, Bhattacharya S, Patel S, Wetzel K, Woerle H-J. C-Peptide Levels in Latent Autoimmune Diabetes in Adults Treated With Linagliptin Versus Glimepiride: Exploratory results from a 2-year, double-blind, randomised, controlled study. Diabetes Care 2014; 37:e11–e12
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hummel, M., Füchtenbusch, M. Typ-1-Diabetes, LADA oder „Doppeldiabetes“?. MMW - Fortschritte der Medizin 159, 52–55 (2017). https://doi.org/10.1007/s15006-017-9579-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-017-9579-4